Stryker, Johnson & Johnson and Zimmer Biomet posted their second-quarter financial results for 2025 and data on their spine orthopedic sales.
Here is how they compare:
Total sales: $6 billion (+11.1%)
Orthopedics: $2.2 billion (+2%)
Hips: $466 million (+8.9%)
Knees: $640 million (+6.3%)
Spine: $5 million
Net earnings: $884 million
Total sales: $2.07 billion (+7%)
Hips: $536.1 million (+5.8%)
Knees: $826 million (+3.1%)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $550.6 million (+17.3%)
Net earnings: $152.8 million
Medtech sales: $8.5 billion (+7.3%)
Orthopedic: $2.3 billion (-3%)
Spine, sports and other: $727 million (-2.1%)
Hips: $421 million (+1%)
Knees: $389 million (-1.1%)
Net earnings: $5.5 billion
